The complex interplay between inflammation, the microbiota and colorectal cancer

Gut Microbes

Volumn 4, Issue 3, 2013, Pages 253-258

  Arthur, Janelle C ^a   Jobin, Christian ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial toxin; Colibactin; Colon cancer; Escherichia coli; Inflammation; Microbiome

Indexed keywords

DNA 16S; RNA 16S; BACTERIAL TOXIN; COLIBACTIN;

ARTICLE; BACTERIUM COLONY; CARCINOGENESIS; CARCINOGENICITY; COLORECTAL CANCER; DISEASE ASSOCIATION; ENTERITIS; ESCHERICHIA COLI; GENOTOXICITY; HELICOBACTER INFECTION; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; POLYMERASE CHAIN REACTION; ANIMAL; BACTERIUM; COLON CANCER; COLORECTAL TUMOR; GASTROINTESTINAL TRACT; IMMUNOLOGY; METAGENOME; MICROBIOLOGY; MICROBIOME; PATHOGENICITY; PATHOLOGY;

BACTERIAL TOXIN; COLIBACTIN; COLON CANCER; ESCHERICHIA COLI; INFLAMMATION; MICROBIOME;

ANIMALS; BACTERIA; COLORECTAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; METAGENOME;

EID: 84877248514     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.24220     Document Type: Article

References (44)

1. Heidland A, Klassen A, Rutkowski P, Bahner U. The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance? J Nephrol 2006; 19(Suppl 10):S102-9; PMID:16874721.
2. Chiba T, Marusawa H, Ushijima T. Inflammationassociated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143:550-63; PMID:22796521; http://dx.doi.org/10.1053/j.gastro. 2012.07.009.
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-45; PMID:11229684; http://dx.doi.org/10.1016/S0140-6736(00)04046-0.
4. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140:1807-16; PMID:21530747; http://dx.doi.org/10.1053/j.gastro. 2011.01.057.
5. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117:1175-83; PMID:17476347; http://dx.doi.org/10.1172/JCI31537.
6. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13:R79; PMID:23013615; http://dx.doi.org/10.1186/gb-2012-13-9-r79.
7. Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 2008; 14:858-67; PMID:18275077; http://dx.doi.org/10.1002/ ibd.20392.
8. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inf lammation targets cancer-inducing activity of the microbiota. Science 2012; 338:120-3; PMID:22903521; http://dx.doi.org/10.1126/science. 1224820.
9. Marshall BJ. The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA 1995; 274:1064-6; PMID:7563460; http://dx.doi.org/10.1001/ jama.274.13.1064.
10. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297:800-2; PMID:408687; http://dx.doi. org/10.1056/NEJM197710132971503.
11. Boleij A, van Gelder MMHJ, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011; 53:870-8; PMID:21960713; http://dx.doi. org/10.1093/cid/cir609.
12. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8; PMID:11352068; http://dx.doi.org/10.1126/science. 1058709.
13. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-30; PMID:22972295; http://dx.doi.org/10.1038/ nature11550.
14. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012; 13:47-58; PMID:22179717; http:// dx.doi.org/10.1038/nrg3129.
15. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6:e16393; PMID:21297998; http://dx.doi. org/10.1371/journal.pone.0016393.
16. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6:320-9; PMID:21850056; http:// dx.doi.org/10.1038/ismej.2011.109.
17. Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 2012; 6:1858-68; PMID:22622349; http://dx.doi. org/10.1038/ismej.2012.43.
18. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, et al. Towards the human colorectal cancer microbiome. PLoS One 2011; 6:e20447; PMID:21647227; http://dx.doi.org/10.1371/journal. pone.0020447.
19. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22:292-8; PMID:22009990; http://dx.doi.org/10.1101/gr.126573.111.
20. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22:299-306; PMID:22009989; http://dx.doi.org/10.1101/ gr.126516.111.
21. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012; 7:e39743; PMID:22761885; http://dx.doi. org/10.1371/journal.pone.0039743.
22. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 2011; 17:1971-8; PMID:21830275; http://dx.doi. org/10.1002/ibd.21606.
23. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127:80-93; PMID:15236175; http://dx.doi.org/10.1053/j.gastro. 2004.03.054.
24. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405-13; PMID:9834268; http://dx.doi. org/10.1016/S0016-5085(98)70019-8.
25. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998; 115:281-6; PMID:9679033; http://dx.doi.org/10.1016/S0016-5085(98)70194-5.
26. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9:219-30; PMID:22349170; http://dx.doi.org/10.1038/nrgastro. 2012.14.
27. Uronis JM, Mühlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009; 4:e6026; PMID:19551144; http://dx.doi.org/10.1371/journal. pone.0006026.
28. Ubeda C, Lipuma L, Gobourne A, Viale A, Leiner I, Equinda M, et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med 2012; 209:1445-56; PMID:22826298; http:// dx.doi.org/10.1084/jem.20120504.
29. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93; PMID:15082587; http://dx.doi. org/10.1136/gut.2003.025403.
30. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-11; PMID:16188921; http://dx.doi.org/10.1136/ gut.2005.073817.
31. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8:292-300; PMID:20833380; http:// dx.doi.org/10.1016/j.chom.2010.08.004.
32. Luperchio SA, Schauer DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 2001; 3:333-40; PMID:11334751; http://dx.doi.org/10.1016/S1286-4579(01)01387-9.
33. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1:138-47; PMID:20740058; http://dx.doi.org/10.4161/ gmic.1.3.12360.
34. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005; 128:891-906; PMID:15825073; http://dx.doi. org/10.1053/j.gastro.2005.02.009.
35. Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313:848-51; PMID:16902142; http://dx.doi.org/10.1126/science.1127059.
36. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010; 107:11537-42; PMID:20534522; http:// dx.doi.org/10.1073/pnas.1001261107.
37. Homburg S, Oswald E, Hacker J, Dobrindt U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett 2007; 275:255-62; PMID:17714479; http://dx.doi.org/10.1111/j.1574-6968.2007.00889.x.
38. Putze J, Hennequin C, Nougayrède JP, Zhang W, Homburg S, Karch H, et al. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 2009; 77:4696-703; PMID:19720753; http://dx.doi.org/10.1128/IAI.00522-09.
39. Olier M, Marcq I, Salvador-Cartier C, Secher T, Dobrindt U, Boury M, et al. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 2012; 3:501-9; PMID:22895085; http://dx.doi. org/10.4161/gmic.21737.
40. Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis 2011; 17:396-409; PMID:20848537; http://dx.doi. org/10.1002/ibd.21354.
41. Patwa LG, Fan TJ, Tchaptchet S, Liu Y, Lussier YA, Sartor RB, et al. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 2011; 141:1842-51, e1-10; PMID:21726510; http://dx.doi. org/10.1053/j.gastro.2011.06.064.
42. Rhodes JM, Campbell BJ. Inf lammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002; 8:10-6; PMID:11796261; http://dx.doi.org/10.1016/S1471-4914(01)02194-3.
43. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491:254-8; PMID:23034650.
44. Cougnoux A, Gibold L, Robin F, Dubois D, Pradel N, Darfeuille-Michaud A, et al. Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP. J Mol Biol 2012; 424:203-14; PMID:23041299; http://dx.doi.org/10.1016/j. jmb.2012.09.017.